SOM logo

SomnoMed Limited Stock Price

ASX:SOM Community·AU$176.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

SOM Share Price Performance

AU$0
-0.40 (-100.00%)
AU$0
-0.40 (-100.00%)
Price AU$0

SOM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and undervalued.

0 Risks
4 Rewards

SomnoMed Limited Key Details

AU$111.5m

Revenue

AU$44.8m

Cost of Revenue

AU$66.7m

Gross Profit

AU$70.2m

Other Expenses

-AU$3.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.016
59.85%
-3.10%
1.7%
View Full Analysis

About SOM

Founded
1987
Employees
n/a
CEO
Amrita Blickstead
WebsiteView website
somnomed.com/au/

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Recent SOM News & Updates

Recent updates

No updates